TW200716759A - Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test - Google Patents

Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test

Info

Publication number
TW200716759A
TW200716759A TW095113360A TW95113360A TW200716759A TW 200716759 A TW200716759 A TW 200716759A TW 095113360 A TW095113360 A TW 095113360A TW 95113360 A TW95113360 A TW 95113360A TW 200716759 A TW200716759 A TW 200716759A
Authority
TW
Taiwan
Prior art keywords
cyp2d6
composition
breath test
cytochrome
breath
Prior art date
Application number
TW095113360A
Other languages
English (en)
Inventor
Anil S Modak
Yasuo Irie
Yasuhisa Kurogi
Original Assignee
Otsuka Pharma Co Ltd
Cambridge Isotope Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Cambridge Isotope Lab Inc filed Critical Otsuka Pharma Co Ltd
Publication of TW200716759A publication Critical patent/TW200716759A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Atmospheric Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW095113360A 2005-04-16 2006-04-14 Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test TW200716759A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67178405P 2005-04-16 2005-04-16

Publications (1)

Publication Number Publication Date
TW200716759A true TW200716759A (en) 2007-05-01

Family

ID=37115218

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095113360A TW200716759A (en) 2005-04-16 2006-04-14 Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test

Country Status (9)

Country Link
US (2) US20070026480A1 (zh)
EP (1) EP1877554A1 (zh)
JP (1) JP2008538275A (zh)
KR (1) KR20080005556A (zh)
CN (1) CN101163791A (zh)
AU (1) AU2006237863A1 (zh)
CA (1) CA2606136C (zh)
TW (1) TW200716759A (zh)
WO (1) WO2006112513A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8622920B2 (en) * 2005-11-11 2014-01-07 Exalenz Bioscience Ltd. Breath test device and method
US8512258B2 (en) 2005-11-11 2013-08-20 Exalenz Bioscience Ltd. Breath test device and method
US7833744B2 (en) * 2006-09-01 2010-11-16 Cambridge Isotope Laboratories, Inc. Methods to evaluate cytochrome P450 2C19 isoenzyme activity using a breath test
GB2442980B (en) * 2006-10-18 2011-11-23 Autoliv Dev Improvements in or relating to detection of substances in a subject
US8321151B2 (en) 2008-12-30 2012-11-27 The Invention Science Fund I, Llc Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity
US8073632B2 (en) * 2008-12-30 2011-12-06 The Invention Science Fund I, Llc Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity
US8315815B2 (en) 2008-12-30 2012-11-20 The Invention Science Fund I, Llc Computational methods and systems for suggesting modulators of CYP450 as treatment options
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
JP5770997B2 (ja) * 2009-12-09 2015-08-26 大塚製薬株式会社 Ｃｙｐ３ａ４の代謝機能測定方法
ES2613506T3 (es) * 2010-08-19 2017-05-24 Otsuka Pharmaceutical Co., Ltd. Método para la medición cuantitativa de acidez gástrica usando sal de carbonato con 13C
DE102011007310A1 (de) * 2011-04-13 2012-10-18 Humedics Gmbh Verfahren zur Bestimmung der metabolischen Leistung mindestens eines Enzyms
JP6024939B2 (ja) * 2011-10-12 2016-11-16 国立大学法人金沢大学 薬物代謝機能測定方法
EP2887066B1 (en) 2012-08-20 2020-08-05 Otsuka Pharmaceutical Co., Ltd. Composition for use in a method for measuring carbohydrate metabolism ability
KR20210014204A (ko) 2013-03-15 2021-02-08 오츠카 세이야쿠 가부시키가이샤 지방산 연소에 의한 인슐린 저항성의 측정 방법, 및 그에 사용하는 조성물
CA3199343A1 (en) 2015-11-30 2017-06-08 Concordia University Inc. Compositions for cyp450 phenotyping using saliva samples
EP3664791A4 (en) 2017-08-07 2021-05-05 Concordia University, Inc. EPLERENONE FOR THE PHENOTYPING OF CYP3A5 ENZYMACTIVITY IN SALIVA SAMPLES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US6207648B1 (en) * 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
US6778269B2 (en) * 2001-09-04 2004-08-17 Board Of Regents, The University Of Texas System Detecting isotopes and determining isotope ratios using raman spectroscopy
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
JP2006508339A (ja) * 2002-09-20 2006-03-09 プロメガ　コーポレイション シトクロムｐ４５０活性を測定するための発光を利用する方法およびプローブ
US20090005270A1 (en) * 2004-09-20 2009-01-01 University Of Florida Research Foundation, Inc. Systems and Methods for Evaluating Enzyme Competency

Also Published As

Publication number Publication date
CA2606136A1 (en) 2006-10-26
CN101163791A (zh) 2008-04-16
US20070026480A1 (en) 2007-02-01
KR20080005556A (ko) 2008-01-14
US20100329979A1 (en) 2010-12-30
EP1877554A1 (en) 2008-01-16
AU2006237863A1 (en) 2006-10-26
CA2606136C (en) 2014-07-29
WO2006112513A1 (en) 2006-10-26
JP2008538275A (ja) 2008-10-23

Similar Documents

Publication Publication Date Title
TW200716759A (en) Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test
WO2008028116A3 (en) Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test
Blech et al. The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans
van den Anker et al. Developmental changes in pharmacokinetics and pharmacodynamics
EP2073706A4 (en) TISSUE PERFUSION ANALYSIS SYSTEM BASED ON THE USE OF INDOCYANINE GREEN CONCENTRATION IN BLOOD
Hannig et al. Immobilisation and activity of human α-amylase in the acquired enamel pellicle
EP1546162A4 (en) METHODS BASED ON LUMINESCENCE AND PROBES FOR MEASURING CYTOCHROME P450 ACTIVITY
HK1123308A1 (en) Stable nad/nadh derivatives
Casellas et al. Applicability of short hydrogen breath test for screening of lactose malabsorption
Lin et al. Differences in the urinary excretion of 6‐β‐hydroxycortisol/cortisol between Asian and Caucasian women
WO2005121366A8 (ja) 遺伝子マーカー及びその利用
GB0509500D0 (en) Method of fetal cell enrichment
Wu et al. Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model
MX2009006560A (es) Un metodo mediante una prueba de aliento para la deteccion de microorganismos patogenos.
Buschini et al. Genetic polymorphism of drug‐metabolizing enzymes and styrene‐induced DNA damage
Hannig et al. Transaminases in the acquired pellicle
Jurica et al. Determination of cytochrome P450 metabolic activity using selective markers
Zhu et al. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein
Gharaibeh et al. Effect of multiple doses of rifampin on the [14C N‐methyl] erythromycin breath test in healthy male volunteers
TW200744646A (en) Method and composition to individualize Levodopa/Carbidopa therapy using a breath test
EP1707219A3 (en) Radioactive kits for a gastric emptying measurement
Lares-Asseff et al. Phenotypical expression of CYP2D6 in Amerindians of Tepehuano origin from Durango, Mexico
Kennedy et al. Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children
Kazmi et al. The Effect of Buffer Ionic Strength or Various Media On the In Vitro Metabolism of Cytochrome P450 Substrates In Pooled Human Liver Microsomes and Cryopreserved Human Hepatocytes
Kurpius et al. Rates of in vivo methylation of desipramine and nortriptyline